Serving the Los Angeles-Long Beach-Anaheim metro area
78 Los Angeles GLP-1 clinic listings include tirzepatide in their listed services. A listing shows what a clinic advertises, not confirmed availability, so check with the clinic before booking. Compare published pricing, insurance details, and reviews below.
Los Angeles has a population of 3,979,576 in the Los Angeles-Long Beach-Anaheim metro area. With a local obesity rate of 25.5%, demand for GLP-1 medications like tirzepatide continues to grow. 78 local listings name tirzepatide, so there are several places to start.
Medicaid coverage: California Medicaid does not currently cover GLP-1 weight loss medications. Patients without commercial insurance coverage may want to explore compounded options or manufacturer savings programs.
Telehealth in California: California permits telehealth prescribing for GLP-1 medications. Providers must hold a California medical license. Medi-Cal no longer covers GLP-1 medications for weight loss as of January 1, 2026. 15 of the 78 Los Angeles listings naming tirzepatide list telehealth.



78 Los Angeles, California clinic listings include Tirzepatide (Mounjaro/Zepbound) in their listed services. A listing tells you where to ask first; prescribing is the clinician's decision after an evaluation. Most of these listings are cash-pay.
Across the 11 of 78 Los Angeles listings that publish a price, Tirzepatide (Mounjaro/Zepbound) programs average $344 to $972 per month. The rest do not list one. Prices depend on dosage, whether you use branded or compounded versions, and your insurance coverage.
15 of the 78 Los Angeles listings that name tirzepatide also list telehealth. California permits telehealth prescribing for GLP-1 medications. Providers must hold a California medical license. Medi-Cal no longer covers GLP-1 medications for weight loss as of January 1, 2026. Whether a given clinic can complete your consultation by video is a question for that clinic.
No. California Medicaid does not currently cover GLP-1 weight loss medications. Patients without commercial insurance coverage may want to explore compounded versions or manufacturer savings programs to reduce costs.
Yes. Mounjaro and Zepbound (brand names for tirzepatide) are FDA-approved for weight management. Your provider will determine the right dosage based on your health history and goals.
Learn about Tirzepatide (Mounjaro/Zepbound) – dosing, side effects, costs, and FDA approval status.
Provider Matching Quiz
Find the right GLP-1 provider in 2 minutes
Compare Telehealth Providers
Side-by-side ratings, pricing, and reviews
Cost & Insurance Guide
Pricing, coverage, and savings programs
GLP-1 Medications
Compare Ozempic, Wegovy, Mounjaro, and more
Weight Loss Calculator
Estimate your results with GLP-1 treatment
GLP-1 Treatment Guides
What to expect when starting treatment
Safety Alerts
FDA warnings and safety updates
Insurance Coverage
Medicare, Medicaid, and private insurance for GLP-1
Appeal a Coverage Denial
Denial decision flow + a free appeal-letter template
2026 Clinic Data Report
Original research from 9,580 verified providers
Our Methodology
How we verify 9,700+ GLP-1 providers
This site is for educational purposes only and is not medical advice. Always consult a healthcare provider before starting any medication. Full disclaimer